CMPX vs KEY
Compass Therapeutics Inc. (CMPX) versus KeyCorp (KEY) — a side-by-side from cached financials, not a winner call.
Compass Therapeutics Inc. (CMPX) is a biotechnology company listed on US.
KeyCorp (KEY) is a banks - regional company listed on US.
CMPX does not have a complete income-statement cache yet.
Latest reported KEY revenue for 2025-12-31 was $7.51B. Net income was $1.83B. Revenue was up 62.7% from 2024-12-31 to 2025-12-31. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
CMPX currently screens at market cap $367.4M. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
Not investment advice. Open the CMPX and KEY stock pages for the full models.
Not investment advice.